Study of the preferences of doctors and pharmacists regarding medicines for the treatment of diseases of the peripheral nervous system
Keywords:diseases of the peripheral nervous system, treatment regimens, drugs, pharmacists, doctors
The aim of the work is to assess the preferences of doctors and pharmaceutical workers regarding drugs for the treatment of diseases of the peripheral nervous system in order to optimize the medical supply of the population.
Materials and methods. Data from the State Register of Medicines of Ukraine, Compendium-online, questionnaires of neurologists and pharmaceutical workers were used in this research. The search systematic, analytical, qualimetric, comparative, statistical analyses were used in the work.
Results. The results of a survey of neurologists revealed that for the treatment of diseases of the peripheral nervous system (radiculopathy, radiculalgia) the most effective treatment regimen is that, which includes “Nucleo CMF Forte”, “Celtican” and “Myelofan”. The effectiveness and safety of the studied drugs were confirmed by qualimetric analysis. However, the results of consumer surveys showed that the latter prefer a treatment regimen that contains “Dicloberl”, “Ketanov” and “Dexalgin”. These drugs are the most irrational in terms of side effects and contraindications. For consumers, the importance of the pharmacological effect outweighs the effects on the body from the side effects of drugs.
Conclusions. The study of the preferences of doctors and pharmacists regarding medicines for the treatment of radiculopathy and radiculalgia was conducted. The most rational treatment regimens are identified, the effectiveness of which is confirmed by the method of qualitative analysis.
Svyrydova, N. K., Chuprina, H. N., Parnykoza, T. P., Sereda, V. H., & Kustkova, A. S. (2015). Radykulopatii ta korintsevi vertebrohenni syndromy [Radiculopathy and radicular vertebrogenic syndromes]. Skhidno-yevropeiskyi nevrolohichnyi zhurnal, (2), 39-48. [in Ukrainian].
Tarulli, A. W., & Raynor, E. M. (2007). Lumbosacral radiculopathy. Neurologic clinics, 25(2), 387–405. https://doi.org/10.1016/j.ncl.2007.01.008
Schoenfeld, A. J., Laughlin, M., Bader, J. O., & Bono, C. M. (2012). Characterization of the incidence and risk factors for the development of lumbar radiculopathy. Journal of spinal disorders & techniques, 25(3), 163-167. https://doi.org/10.1097/BSD.0b013e3182146e55
Jordan, J., Konstantinou, K., & O'Dowd, J. (2009). Herniated lumbar disc. BMJ clinical evidence, 2009, 1118. https://doi.org/10.3171/jns.1994.81.5.0806b
Berry, J. A., Elia, C., Saini, H. S., & Miulli, D. E. (2019). A Review of Lumbar Radiculopathy, Diagnosis, and Treatment. Cureus, 11(10), e5934. https://doi.org/10.7759/cureus.5934
Kovalenko O. Ye., Macheret Ye. L., Halusha A. I. (2011). Viddaleni nevrolohichni naslidky lehkykh vertebralnykh travm [Long-term neurological consequences of mild vertebral injuries]. Zdorovia Ukrainy, (2), 9-11. [in Ukrainian].
Gotsulya, A. S., Pruglo, Ye. S., Panasenko, O. I., & Knysh, Ye. G. (2014). Protyzapalna aktyvnist solei 2-(5-((teofilin-7-il)metyl)-4-R-4N-1,2,4-triazol-3-iltio)atsetatnoi kysloty [Anti-inflammatory activity of 2-(5-((theophylline-7’-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetic acid salts]. Current issues in pharmacy and medicine: science and practice, (3), 60-62. [in Ukrainian].
Kompendium - Likarski zasoby [Compendium - Drugs]. [in Ukrainian]. http://compendium.com.ua/
Ministry of Health of Ukraine. (n.d.). Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines of Ukraine]. http://www.drlz.kiev.ua
Dmytrenko, H. A., Anufriieva, O. L., Burlaienko, T. I., & Medvid, V. V. (2016). Kvalimetriia v upravlinni: humanistychnyi kontekst [Qualimetrics in management:a humanistic context]. Kyiv: Vydavnytstvo "Ahrarna osvita". [in Ukrainian].
Kuts, V. R., Stoliarchuk, P. H., & Druziuk, V. M. (2012). Kvalimetriia [Qualimetrics]. Lviv: Vydavnytstvo Natsionalnoho universytetu "Lvivska politekhnika". [in Ukrainian].
Posylkina, O. V., & Demchenko, N. V. (2014) Metodolohichni i metodychni aspekty otsinky konkurentospromozhnosti farmatsevtychnykh pidpryiemstv [Methodological and methodical aspects of pharmaceutical companies competitiveness assessment]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (2), 28-35. [in Ukrainian].
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)